Skip to content
Screener

Astrana Health ASTH Total Equity

Total Equity at other companies

CVS Health logo
CVS HealthCVS
$79.7B+3.0%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$782.33M+14.6%
Agilon Health logo
Agilon HealthAGL
$227.53M-44.4%
ARD
Ardent Health PartnersARDT
$1.34B+13.8%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$383.22M-57.2%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$1.98B+17.3%

Other financials

Income statement

See full
Revenue$965.1M+55.6%
Gross profit$105.7M+48.2%
Operating income$28.5M+38.6%
Net income$14.4M+116%
EPS (diluted)$0.29+107%

Balance sheet

See full
Cash & equivalents$478.4M+85.0%
Total debt$1.1B+136%
Total assets$2.4B+77.2%

Cash flow

See full
Operating cash flow$68.1M+309%
CapEx$4.0M+30.3%
Free cash flow$64.1M+372%

Valuation

See full
Market cap$1.69B+68.1%
Enterprise value$2.28B+104%
P/E56×
P/S0.5×+0.1×

Profitability

See full
Gross margin10.7%-1.3pp
Operating margin2.5%-1.1pp
Net margin0.9%
FCF margin4.6%

Returns & leverage

See full
Return on equity3.9%
Debt / equity1.3×+0.7×
Current ratio1.3×-0.4×

Where this comes from

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Astrana Health’s 10-Q, filed May 8, 2026.

Filed
May 8, 2026, 6:01 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-213157
Line itemMarch 31,2026December 31,2025
Preferred stock, $0.001 par value per share; 5,000,000 shares authorized; and zero shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 48,946,399 and 48,885,358 shares issued and outstanding, excluding 10,695,758 and 10,571,011 treasury shares, as of March 31, 2026 and December 31, 2025, respectively4949
Additional paid-in capital477,508470,863
Retained earnings322,711308,379
Total stockholders’ equity800,268779,291
Non-controlling interests14,92714,005
Total equity815,195793,296
Total liabilities, mezzanine deficit, and stockholders’ equity$2,358,827$2,218,661

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Astrana Health's total equity?
Astrana Health (ASTH) reported total equity of $800.27M in Q1 2026.
How has Astrana Health's total equity changed year-over-year?
Astrana Health's total equity increased by 7.4% year-over-year, from $745.37M to $800.27M.
What is the long-term trend for Astrana Health's total equity?
Over 5 years (2020 to 2025), Astrana Health's total equity has grown at a 18.7% compound annual growth rate (CAGR), from $330.82M to $779.29M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Astrana Health's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude